EPO Patents = 2

Forward Citations = 6

Loading Chart...

6 inventors (with patents filed for the assignee):

Robin Mark Bannister (6 out of 76 patents)

John Brew (5 out of 61 patents)

Andrew Douglas Baxter (2 out of 44 patents)

4. Gregory Alan Stoloff (1 out of 42 patents)

5. Wilson Romero Caparros-Wanderley (1 out of 28 patents)

6. Michael Harvey Lyne (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 9849110 - Intermittent fibrate administration method (2017-12-26),

2. 9539240 - Drug combinations and methods for reducing or maintaining cholesterol or HDL/LDL levels (2017-01-10),

3. 9056140 - Pharmaceutical compound (2015-06-16),

4. 8703158 - Theobromine for the treatment of cough (2014-04-22),

5. 8188152 - 2-aminoalcohols for the treatment of neurodegenerative diseases (2012-05-29),

6. 8188150 - Use of beta-aminoalcohols in the treatment of inflammatory disorders and pain (2012-05-29),

7. 8030357 - Use of bupropion metabolites for the treatment of inflammatory disorders (2011-10-04),

Biocopea Limited is a leading provider of innovative and sustainable solutions for the pharmaceutical and biotechnology industries. With a focus on research and development, Biocopea specializes in creating cutting-edge products and technologies that help improve patient outcomes and drive the industry forward. Their team of experts is dedicated to delivering high-quality solutions that meet the unique needs of each client and contribute to a healthier world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#386 in London

#2,286 in United Kingdom

London, United Kingdom

Biocopea Limited